Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Express Scripts
Harvard Business School
Medtronic
McKinsey

Last Updated: April 5, 2020

DrugPatentWatch Database Preview

Barr Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BARR, and what generic and branded alternatives to BARR drugs are available?

BARR has one hundred and seventy-five approved drugs.

There are seven tentative approvals on BARR drugs.

Summary for Barr
US Patents:0
Tradenames:122
Ingredients:96
NDAs:175
Patent Litigation for Barr: See patent lawsuits for Barr

Drugs and US Patents for Barr

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr DIAZEPAM diazepam TABLET;ORAL 070154-001 Nov 1, 1985 AB RX No No   Start Trial   Start Trial
Barr DANAZOL danazol CAPSULE;ORAL 074582-003 May 29, 1998 AB RX No No   Start Trial   Start Trial
Barr TRIAMCINOLONE triamcinolone TABLET;ORAL 084318-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Barr PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 084831-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Barr TEMOZOLOMIDE temozolomide CAPSULE;ORAL 078879-005 Mar 1, 2010 AB RX No No   Start Trial   Start Trial
Barr NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone TABLET, CHEWABLE;ORAL 078965-001 Aug 5, 2010 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.